Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan

Koichi Takaguchi; Hidenori Toyoda; Akemi Tsutsui; Yoshiyuki Suzuki; Makoto Nakamuta; Michio Imamura; Tomonori Senoh; Takuya Nagano; Toshifumi Tada; Yoshihiko Tachi; Atsushi Hiraoka; Kojiro Michitaka; Hiroshi Shibata; Kouji Joko; Hironao Okubo; Kunihiko Tsuji; Shintaro Takaki; Tsunamasa Watanabe; Chikara Ogawa; Kazuaki Chayama; Takashi Kumada; Masatoshi Kudo; Hiromitsu Kumada

doi:10.1007/s00535-019-01568-8

Back

Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan

Article 2019 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection

Hiroshi Ida, Satoru Hagiwara, Masashi Kono, Tomohiro Minami, Hirokazu Chishina, Tadaaki Arizumi, Masahiro Takita, Norihisa Yada, Yasunori Minami, Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo

Article2016

Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2

Kayo Sugimoto, Soo Ki Kim, Soo Ryang Kim, Mana Kobayashi, Airi Kato, Eri Morimoto, Susumu Imoto, Chi Wan Kim, Yasuhito Tanaka, Masatoshi Kudo, Yoshihiko Yano, Yoshitake Hayashi

Article2016

Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2

Naoshi Nishida, Masashi Kono, Tomohiro Minami, Hirokazu Chishina, Tadaaki Arizumi, Masahiro Takita, Norihisa Yada, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, Tashiharu Sakurai, Masatoshi Kudo

Article2013

miR-122, IL28B genotype and the response to interferon in chronic hepatitis C virus infection

Jae Il Shin, Michael Eisenhut

Article2016

Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response

Masatoshi Kudo